TBX20 is a T-box transcription factor essential for cardiac development and adult heart function, acting as both transcriptional activator and repressor 1. During embryogenesis, TBX20 regulates multiple cardiac morphogenic processes including chamber septation, valvulogenesis, and outflow tract development 2. Mechanistically, TBX20 colocalizes with other cardiac transcription factors (MEF2C, GATA4, TBX5) at cardiac gene enhancers to promote robust activation of genes controlling heart contraction and mitochondrial function 1. TBX20 specifically controls KCNH2 gene expression, regulating hERG channels critical for cardiac repolarization 3. Clinically, TBX20 mutations have substantial disease relevance. Meta-analysis indicates TBX20 mutations significantly increase congenital heart disease (CHD) risk (pooled OR = 5.73) 4, particularly affecting atrial septal defects 2. Promoter variants alter TBX20 transcriptional activity in dilated cardiomyopathy patients 5, while childhood-onset cardiomyopathies involve TBX20 mutations affecting cardiac development pathways 6. Functionally, TBX20 addition to reprogramming cocktails enhances human cardiomyocyte generation with improved contractility and mitochondrial respiration 1, suggesting therapeutic potential for cardiac regeneration and potentially informing future diagnostic and treatment strategies for CHD and cardiomyopathies 4.